IDYA · Ideaya Biosciences Inc
United States · RS rating 40 · As of 2026-11-03
| Price | 31.33 USD |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 40 / 24 / 40 / 49 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 24 / 36 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -170.7% |
| Sales growth Q/Q | -94.8% |
| Distance from 52-week high | +26.2% |
| Market cap (USD) | $2.7B |